Identification of differentially expressed genes between osteoblasts and osteocytes

Abstract

Osteocytes represent the most abundant cellular component of mammalian bones with important functions in bone mass maintenance and remodeling. To elucidate the differential gene expression between osteoblasts and osteocytes we completed a comprehensive analysis of their gene profiles. Selective identification of these two mature populations was achieved by utilization of visual markers of bone lineage cells. We have utilized dual GFP reporter mice in which osteocytes are expressing GFP (topaz) directed by the DMP1 promoter, while osteoblasts are identified by expression of GFP (cyan) driven by 2.3kb of the Col1a1 promoter. Histological analysis of 7-day-old neonatal calvaria confirmed the expression pattern of DMP1GFP in osteocytes and Col2.3 in osteoblasts and osteocytes. To isolate distinct populations of cells we utilized fluorescent activated cell sorting (FACS). Cells suspensions were subjected to RNA extraction, in vitro transcription and labeling of cDNA and gene expression was analyzed using the Illumina WG-6v1 BeadChip.Following normalization of raw data from four biological replicates, 3444 genes were called present in all three sorted cell populations: GFP negative, Col2.3cyan + (osteoblasts), and DMP1topaz + (preosteocytes and osteocytes). We present the genes that showed in excess of a 2-fold change for gene expression between DMP1topaz + and Col2.3cyan + cells. The selected genes were classified and grouped according to their associated gene ontology terms. Genes clustered to osteogenesis and skeletal development such as Bmp4, Bmp8a, Dmp1, Enpp1, Phex and Ank were highly expressed in DMP1topaz + cells. Most of the genes encoding extracellular matrix components and secreted proteins had lower expression in DMP1topaz + cells, while most of the genes encoding plasma membrane proteins were increased. Interestingly a large number of genes associated with muscle development and function and with neuronal phenotype were increased in DMP1topaz + cells, indicating some new aspects of osteocyte biology. Although a large number of genes differentially expressed in DMP1topaz + and Col2.3cyan + cells in our study have already been assigned to bone Contact Information: Ivo Kalajzic, Department of Reconstructive Sciences, MC 3705, University of Connecticut Health Center, 263 Farmington Ave., Farmington, CT 06032. Tel.: 860-679-6051; Fax: 860-679-2910; ikalaj@neuron.uchc.edu. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. NIH Public Access Author ManuscriptBone. Author manuscript; available in PMC 2010 October 1. NIH-PA Author ManuscriptNIH-PA Author Manuscript NI...

Decline in calcitonin receptor expression in osteocytes with age

“…Our previous work identifying CTR expression in osteocytes made use of calvarial bone specimens in young mice (Gooi et al 2010), and the same is true of the work of Paic et al (2009) that described Calcr in isolated osteocytes. Our current work suggests that CTR expression by osteocytes is not constant, but is reduced as rodents age, most dramatically in the long bones.…”

“…In addition to any coupling-mediated actions, we found that sCT treatment also increased the expression of sclerostin (Gooi et al 2010), an inhibitor of bone formation that is secreted by osteocytes. This stimulation of sclerostin by sCT is likely to be mediated by CT receptors (CTRs) that we, and others, identified in bone matrixembedded osteocytes (Paic et al 2009, Gooi et al 2010. PTH anabolic action suppresses sclerostin production (Bellido et al 2005, Leupin et al 2007 and PTH anabolic action is limited in mice that overexpress sclerostin (Kramer et al 2010).…”

The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro

“…In contrast, these cells had low levels of expression of genes characteristic of immature osteocytes and late osteoblasts, such as keratocan (Fig. 2B) (42,43). After 1 week in culture at 37°C, Ocy454 cells expressed levels of DMP1 (Fig.…”

Osteocyte Wnt/β-Catenin Signaling Is Required for Normal Bone Homeostasis

“…Moreover, it was recently demonstrated that bone homeostasis and adaptation to regular or diminished skeletal loading are strongly disturbed in mice selectively depleted of osteocytes (61). Therefore, while osteocytes are cellular descendants of former bone matrix-producing osteoblasts, osteocytes have a unique cellular identity that is reflected by their specific location inside the bone matrix, their specialized cellular morphology adapted to being trapped in the mineralized bone compartment, and finally a specific molecular signature that clearly distinguishes osteoblasts and osteocytes from each other (52).…”